Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREVENT: Century Clot-Guided Rivaroxaban for Post-STEMI LVT
NCT06013020Phase 4Recruiting
- Sponsor
- Zunyi Medical University
- Start
- Apr 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rivaroxaban in left ventricular thrombus (LVT), sponsored by Zunyi Medical University. Started Apr 2024; status: recruiting.
02
Drugs
rivaroxaban
03
Conditions
left ventricular thrombus (LVT)
Beyond the preview
Go deeper on NCT06013020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06013020.